The Published Guideline for Managing Filler Vascular Occlusion

In 2021, a UK group of clinicians who specialize in aesthetic complications published a practical guideline for managing blood-vessel blockage after hyaluronic acid filler. Its core principles are to recognize the problem quickly, stop injecting, dissolve the filler promptly with repeated doses of an enzyme, and follow the patient closely until healed. For patients, it shows what a prepared clinic should have in place and why your after-care instructions matter.

Why a guideline was needed

A vascular occlusion happens when filler enters or presses on a blood vessel, reducing blood flow to the skin. It is uncommon, but without treatment it can lead to skin breakdown and, very rarely, vision loss or stroke when vessels connected to the eye or brain are involved. Before guidelines like this one, advice varied widely, and some recommended treatments had little evidence behind them.

The authors are founding board members of the Complications in Medical Aesthetics Collaborative. They based their advice on a review of the literature and on their own experience managing hundreds of occlusions over several years. The paper reports no funding and no relevant conflicts of interest.

Key principles

Prevention

The guideline says no area of the face should be called "safe"; areas are graded from lower to very high risk instead. It also warns that pulling back on the syringe plunger before injecting, called aspiration, is not a reliable safety check on its own, because studies show it often fails to detect a vessel. It advises against very fine blunt cannulas and stresses telling patients to report severe pain or unusual sensations straight away.

Recognition

Clinicians are advised to check how quickly colour returns to the skin after gentle pressure, comparing both sides of the face. Sudden or increasing pain is a warning sign, though early occlusion does not always cause pain. Patients treated in higher-risk areas, such as the nose, frown area and forehead, should be observed for a period before leaving. Most occlusions show signs immediately or within hours, and the guideline describes stages from pale or lace-like skin through to blisters and wounds.

Treatment

The central step is high-dose hyaluronidase, the enzyme that breaks down hyaluronic acid filler, injected into the affected area and repeated about every hour until blood flow returns. The guideline notes that the enzyme can reach the blocked vessel from the surrounding tissue, so it does not need to be injected directly into the artery. Emergency medicine for allergic reactions should be on hand.

Supporting measures

The guideline suggests aspirin may be considered if safe for that person, along with massage and warmth. It advises against several adjuncts used elsewhere, including topical nitroglycerin paste, and does not support routine steroids or antibiotics unless there is a clear reason. It describes the evidence for hyperbaric oxygen as weak.

Follow-up

Every patient should receive warning-sign information and emergency contact details. A suspected occlusion should be seen in person urgently, reviewed again the next day even if it seems resolved, and followed until fully healed if the skin has broken down.

How strong is this evidence?

This is a consensus-style guideline based on literature and expert experience, not on randomized trials, which would be very difficult to run for a rare emergency. Much of its dosing advice is drawn from laboratory and animal studies and clinical experience. Other groups have published slightly different protocols, and some, such as the newer approaches described in our article on new emergency protocols, include treatments this guideline does not recommend. Guidance will continue to evolve as evidence grows.

It is also worth noting what the guideline is not. It is not a law or a regulatory standard, and it was written by one collaborative group in the United Kingdom. In Canada, clinicians draw on several published consensus documents, their own training and their professional college's expectations. Still, the broad principles in this paper, such as speed, repeated enzyme doses and close follow-up, are shared by most current guidance, which gives patients a fair sense of what good practice looks like.

The guideline also does not provide a specific protocol for vision loss beyond fast enzyme treatment and urgent escalation, reflecting how limited the evidence is for that rare situation.

What it means for you

• Prepared clinics plan ahead. Hyaluronidase, emergency medicines and a written protocol should be on site before any filler is injected.
• Your observations matter. Report severe or worsening pain, skin that turns pale, dusky, blue or blotchy, or blisters and spots over the next few days.
• Vision changes are an emergency. Any change in sight during or after filler needs immediate help.
• Follow-up is part of treatment. If you are asked to return the next day, please do, even if things look better.
• Do not stop prescribed medicines, including blood thinners, without speaking to the doctor who prescribed them.

Our article on vascular occlusion safety gives more background, and dissolving filler explains how hyaluronidase works.

Questions to ask at your consultation

• Do you follow a written protocol for vascular occlusion, and is hyaluronidase kept on site?
• How do you check blood flow before I leave?
• What number do I call if I am worried after hours?

At HealthPark, we explain our emergency preparation and after-care plan during the consent conversation before filler treatment.

Frequently asked questions

Does this apply to all fillers?

No. The guideline is for hyaluronic acid filler, which can be dissolved. Non-hyaluronic acid fillers cannot be broken down with this enzyme.

Can I be allergic to hyaluronidase?

Allergic reactions are possible but uncommon. In an emergency, the benefit of treatment usually outweighs this risk, which is why clinics keep allergy medicines ready.

Is a blockage always painful?

Not always, especially early on. Changes in skin colour are just as important to report.

If you have questions about filler safety, a consultation is a good opportunity to ask how complications are prevented and managed before deciding on any treatment.

Source

Murray G, Convery C, Walker L, Davies E. Guideline for the management of hyaluronic acid filler-induced vascular occlusion. Journal of Clinical and Aesthetic Dermatology, 2021. Read the study